Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Vestal Point Capital, LP reported a 5.00% stake in Taysha Gene Therapies, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Vestal Point Capital, LP reported a 5.00% stake in Taysha Gene Therapies, Inc., 13,750,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 13,750,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 5.00% | 13,750,000 |
| Ryan Wilder | 5.00% | 13,750,000 |
Source
Related
- Taysha Gene Therapies, Inc.
- Vestal Point Capital, LP
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Stalfort John A III · Jun 2, 2026
- Form 4 · Donenberg Phillip B. · Jun 2, 2026